Prostanoid EP4 receptor is involved in suppression of 3T3-L1 adipocyte differentiation.
about
Novel suppression mechanism operating in early phase of adipogenesis by positive feedback loop for enhancement of cyclooxygenase-2 expression through prostaglandin F2α receptor mediated activation of MEK/ERK-CREB cascadeProstaglandin E2 inhibits matrix mineralization by human bone marrow stromal cell-derived osteoblasts via Epac-dependent cAMP signalingEndogenous synthesis of prostacyclin was positively regulated during the maturation phase of cultured adipocytes.Synergistic suppression of early phase of adipogenesis by microsomal PGE synthase-1 (PTGES1)-produced PGE2 and aldo-keto reductase 1B3-produced PGF2α.Cyclooxygenase-2 deficiency attenuates adipose tissue differentiation and inflammation in miceExpression of genes related to prostaglandin synthesis or signaling in human subcutaneous and omental adipose tissue: depot differences and modulation by adipogenesis.Prostaglandin E₂-EP4 signaling suppresses adipocyte differentiation in mouse embryonic fibroblasts via an autocrine mechanismProstaglandin (PG) F2 alpha synthesis in human subcutaneous and omental adipose tissue: modulation by inflammatory cytokines and role of the human aldose reductase AKR1B1.Age-related changes in bone morphology are accelerated in group VIA phospholipase A2 (iPLA2beta)-null micePGE2, Kidney Disease, and Cardiovascular Risk: Beyond Hypertension and Diabetes.Coordinate functional regulation between microsomal prostaglandin E synthase-1 (mPGES-1) and peroxisome proliferator-activated receptor γ (PPARγ) in the conversion of white-to-brown adipocytes.Activation of peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) increases the expression of prostaglandin E2 receptor subtype EP4. The roles of phosphatidylinositol 3-kinase and CCAAT/enhancer-binding protein beta.Prostaglandin E2 signals white-to-brown adipogenic differentiation.Suppression of adipocyte differentiation by aldo-keto reductase 1B3 acting as prostaglandin F2alpha synthase.Endogenous 15-deoxy-Delta(12,14)-prostaglandin J(2) synthesized by adipocytes during maturation phase contributes to upregulation of fat storage.Prostaglandins as PPARγ Modulators in Adipogenesis.A potential role of IL-6 in the chito-oligosaccharide-mediated inhibition of adipogenesis.Stimulation of fat storage by prostacyclin and selective agonists of prostanoid IP receptor during the maturation phase of cultured adipocytes.Cultured preadipocytes undergoing stable transfection with cyclooxygenase-1 in the antisense direction accelerate adipogenesis during the maturation phase of adipocytes.Stimulation of NGF expression and secretion in 3T3-L1 adipocytes by prostaglandins PGD2, PGJ2, and Delta12-PGJ2.Rubus suavissimus S. Lee extract increases early adipogenesis in 3T3-L1 preadipocytes.Resistin expression in 3T3-L1 adipocytes is reduced by arachidonic acid.Arachidonic acid-dependent gene regulation during preadipocyte differentiation controls adipocyte potential.Pronounced adipogenesis and increased insulin sensitivity caused by overproduction of prostaglandin D2 in vivo.Longitudinal assessment of oxytocin efficacy on bone and bone marrow fat masses in a rabbit osteoporosis model through 3.0-T magnetic resonance spectroscopy and micro-CT.
P2860
Q28586698-A733D0E2-C8F4-4731-BA95-6CECBBF8D6B5Q33714809-9D138236-C698-4898-8D30-BEADF352BC51Q33849477-F3B2279F-13D6-4E4E-8ADE-F5923B20FBEAQ34412709-A15871F5-1DAE-423B-B8D4-6188182F53A0Q34452830-5AA25A88-D276-42B2-8FD6-55AE6526A55DQ34574376-28A00F19-7EF3-41F2-9ECB-7A8883F25CC1Q35107286-919F9569-B482-4E20-A16F-ACF5458D63A5Q35129193-7AD40D26-AC07-4A2C-BA5F-E21780ACC515Q36512269-CBD59F97-ECB6-4AFB-BB3F-B79FD99FD664Q36624751-9B62E313-47B3-49A9-8D8F-29FEAF2A4CD5Q37201286-2FA73EFF-A292-49C4-B740-C5EF364D717CQ38322740-02808DAF-61AF-4FBB-834B-77F6412533F4Q38575787-562DD5E9-FEBE-4287-A235-AC344F328934Q39615733-8FAC5127-F32F-40CE-8FF4-7B9CE0C6B46DQ40200021-6CF4700E-3CF6-4E13-9238-BF14D9F9B6F8Q41873873-08299D18-4DD5-4E47-9B7A-AEB403C7E1C3Q42808511-BA5D49AE-9EE6-4867-A825-FE2222EC3E95Q42813297-B280381A-474D-4F8B-91CB-6F21C77AE84AQ42817241-7332D9C5-C0A9-40AB-9093-FA4321D1D0A5Q42818031-6A553157-9D36-495F-A3F0-4C8DE0E7EC4FQ42818149-9F42366C-2328-4DA6-9CAC-C3B436775D81Q42824457-DB58DD4C-2965-4D32-881A-5AA89E148A10Q42834378-8CBD4548-0AAB-4687-A9B8-FF4B4C41E61DQ43171502-D5A88123-0303-416D-BED1-7F58974C6338Q51054303-EBDA7BC3-3AA2-4651-8399-CFB844E6F7A5
P2860
Prostanoid EP4 receptor is involved in suppression of 3T3-L1 adipocyte differentiation.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Prostanoid EP4 receptor is involved in suppression of 3T3-L1 adipocyte differentiation.
@en
Prostanoid EP4 receptor is involved in suppression of 3T3-L1 adipocyte differentiation.
@nl
type
label
Prostanoid EP4 receptor is involved in suppression of 3T3-L1 adipocyte differentiation.
@en
Prostanoid EP4 receptor is involved in suppression of 3T3-L1 adipocyte differentiation.
@nl
prefLabel
Prostanoid EP4 receptor is involved in suppression of 3T3-L1 adipocyte differentiation.
@en
Prostanoid EP4 receptor is involved in suppression of 3T3-L1 adipocyte differentiation.
@nl
P2093
P1476
Prostanoid EP4 receptor is involved in suppression of 3T3-L1 adipocyte differentiation.
@en
P2093
Atsushi Ichikawa
Hiroaki Tsuboi
Takayuki Kainoh
Yukihiko Sugimoto
P304
P356
10.1016/J.BBRC.2004.08.018
P407
P577
2004-09-01T00:00:00Z